The utilization of artificial intelligence in enterprise imaging has become a significant topic of discussion in the healthcare industry. The potential return on investment for AI in this field is vast, encompassing aspects such as efficiency, accuracy, patient outcomes, and financial considerations. Radiology, in particular, has seen a surge in AI adoption, promising to revolutionize the field by enhancing diagnostic precision and improving patient care.
One of the key challenges in the adoption of AI in enterprise imaging is the lack of direct reimbursement for AI applications in medical imaging. Despite this hurdle, AI has the potential to indirectly contribute to ROI by improving the efficiency of imaging providers, enhancing provider productivity, optimizing staffing efficiencies, and ultimately reducing the overall cost of healthcare delivery.
Dawn Cram, principal consultant at The Gordian Knot Group, will be addressing this complex subject at HIMSS25 in Las Vegas in a session titled “The ROI of AI in Enterprise Imaging.” With over 30 years of healthcare experience, Cram brings a wealth of knowledge and expertise to the discussion of AI ROI in enterprise imaging.
In her session, Cram will delve into the importance of understanding the financial dynamics of AI investments in healthcare organizations. By identifying cost-benefit opportunities and implementing strategies for calculating ROI, healthcare providers can make informed decisions about AI investments that maximize benefits while effectively managing costs.
The session will cover various types of AI technologies, including clinical AI such as pathology detection algorithms and process AI like robotic process automation. By automating routine tasks and streamlining workflows, AI can enable healthcare providers to focus on critical aspects of patient care, leading to improved diagnostic precision and patient outcomes.
Additionally, the session will explore how AI can benefit different imaging specialties throughout the enterprise, such as ophthalmology and dermatology. AI applications in these specialties can aid in early disease detection, improve diagnostic accuracy, and enhance patient care.
One key takeaway from the session will be the importance of deploying responsible AI in healthcare organizations. Validating the development, training, and testing of AI algorithms is crucial to ensuring patient safety, efficacy, and reliability. By adhering to regulatory standards and implementing quality management and monitoring capabilities, healthcare providers can build trust in AI technologies and ensure they are ethical, transparent, and offer high standards of patient care.
Overall, Cram’s session at HIMSS25 will provide attendees with practical tools, tips, and strategies to justify AI investments and achieve sustainable improvements in imaging operations. By understanding the financial implications of AI adoption and deploying responsible AI technologies, healthcare organizations can harness the full potential of AI in enterprise imaging.
Cram’s education session, “The ROI of AI in Enterprise Imaging,” is scheduled for Tuesday, March 4th, at 2 p.m. at HIMSS25 in Las Vegas. For more healthcare IT news and coverage, follow Bill Siwicki on LinkedIn and reach out to him via email at bsiwicki@himss.org.
